Thymulin 20mg

Thymulin 20 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

Thymulin 20 mg is a peptide research preparation developed for controlled laboratory investigations involving peptide biology, molecular signalling and cellular regulatory pathways. The submitted product is identified on the Certificate of Analysis as Thymulin 20 mg. Within the analytical testing section, Liquilabs identifies and characterises the tested peptide as Thymalin, providing batch-specific assay, purity, spectrum, retention time and mass spectrometry results. This preparation contains 20 mg of lyophilized research material supplied in a sealed research vial. Independent analytical testing measured an assay content of 22.3 mg for this production batch. Chromatographic analysis confirmed 99.4 percent purity, while identity was independently evaluated through spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.061 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its independently characterised analytical profile and comprehensive third-party verification, Thymulin 20 mg provides researchers with transparent batch-specific documentation suitable for controlled peptide investigations and in vitro laboratory studies.  

Peptide Overview

Thymulin 20 mg is supplied as a lyophilized peptide research preparation intended exclusively for controlled laboratory investigation. Peptides associated with thymic research have attracted scientific interest within experimental peptide biology, molecular signalling and cellular regulatory research. Researchers may utilise such peptide preparations in controlled experimental models designed to investigate peptide-mediated molecular interactions and biochemical communication systems. Modern analytical techniques allow research preparations to be independently evaluated for assay content, purity and molecular identity before use in laboratory investigations. For this production batch, Liquilabs performed independent peptide screening together with spectrum analysis, retention time evaluation and mass spectrometry identity testing.  

Historical Background and Scientific Context

Thymic peptide research represents an established area of experimental peptide science involving naturally occurring and synthetic peptide structures associated with biological signalling systems. Advances in peptide synthesis and analytical chemistry have significantly improved the ability to manufacture and characterise peptide research compounds under controlled laboratory conditions. Modern chromatographic techniques can determine assay content and purity, while spectrum analysis, retention time comparison and mass spectrometry provide complementary molecular identity information. These analytical techniques can be combined with bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide broader batch-specific analytical documentation. Thymulin 20 mg therefore forms part of the wider field of peptide preparations utilised exclusively for scientific investigation and controlled in vitro research.  

Mechanistic Focus in Research

Within controlled laboratory environments, thymic peptide preparations may be investigated in relation to peptide-mediated signalling, cellular communication and biochemical regulatory systems. Research investigations may explore:

• Thymic peptide research
• Peptide-mediated signalling pathways
• Intracellular molecular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Molecular peptide interactions
• Comparative peptide investigations
• Controlled in vitro peptide studies

These experimental models relate exclusively to scientific and laboratory investigation and do not imply diagnostic, therapeutic or clinical applications.  

Analytical Verification (COA)

Each Grail Formula production batch is supported by independent third-party analytical documentation designed to provide transparent batch-specific information regarding the tested research material. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric and microbiological analytical techniques. Batch: GF-THYMU20-B242

• Product: Thymulin 20 mg
• Analytical Assay Identification: Thymalin
• Assay Content: 22.3 mg
• Purity: 99.4 %
• Identification by Spectrum: 992
• Identification by Retention Time: 0.982
• Molecular Ion Mass Identification: 858 g/mol
• Bacterial Endotoxins: 0.061 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 22.3 mg with a reported analytical uncertainty of ±0.1 mg. Purity analysis confirmed 99.4 percent purity with a reported analytical uncertainty of ±0.5 percent. Identity was evaluated through spectrum analysis with a reported result of 992 and retention time analysis with a result of 0.982. Mass spectrometry reported molecular ion mass identification at 858 g/mol with a stated analytical uncertainty of ±1. Bacterial endotoxin testing returned a result of 0.061 EU/mg, remaining within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent batch-specific documentation of assay content, purity, identity, microbiological quality, endotoxin levels and elemental impurities for the tested research material.  

Research Applications

Within controlled laboratory environments, Thymulin 20 mg may be utilised in experimental models designed to investigate peptide biology, molecular signalling and biochemical regulatory mechanisms. Examples of research applications include:

• Thymic peptide investigations
• Peptide signalling research
• Intracellular signalling investigations
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Molecular interaction research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. For this production batch, independent laboratory testing included:

• Assay content determination
• Purity assessment
• Spectrum-based identification
• Retention time verification
• Molecular ion mass identification
• Bacterial endotoxin analysis
• Total aerobic microbial count
• Total yeast and mold count
• Comprehensive elemental impurity screening
• Complete batch-specific traceability

Independent laboratory testing provides researchers with analytical information relating directly to the tested production batch rather than relying solely on general product specifications. This approach supports analytical transparency, batch traceability and consistency across Grail Formula research compounds.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently analysed research compounds supported by detailed Certificates of Analysis and transparent batch-specific laboratory documentation. For Thymulin 20 mg batch GF-THYMU20-B242, independent analysis was performed by Liquilabs s.r.o. Czechia and the Certificate of Analysis was published on 10 September 2026. The analytical programme includes assay determination, purity assessment, spectrum-based identification, retention time verification, molecular ion mass identification, bacterial endotoxin testing, microbiological analysis and comprehensive elemental impurity screening. This multi-method analytical approach provides researchers with extensive independent information regarding the analytical characteristics of the tested research preparation.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 20 mg Thymulin research preparation
• 99.4 % purity reported by COA
• Assay content measured at 22.3 mg
• Identification evaluated by spectrum and retention time analysis
• Molecular ion mass identification reported at 858 g/mol
• Bacterial endotoxin level of 0.061 EU/mg
• No detectable elemental impurities or microbial contamination
• Complete batch-specific COA traceability
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.